Joe D. Lewis
Corporate Officer/Principal at The European Molecular Biology Laboratory
Profile
Joe D.
Lewis was the founder of Elara Pharmaceuticals GmbH, which was founded in 2006, where he held the title of Chief Executive Officer from 2006 to 2009.
Currently, he is the Head-Chemical Biology at The European Molecular Biology Laboratory.
In the past, he worked as a Group Leader at Anadys Pharmaceuticals, Inc. and as a Group Leader-Wellcome Trust Centre at The University of Edinburgh from 1996 to 2001.
Dr. Lewis holds a doctorate degree from the University of Vienna.
Joe D. Lewis active positions
| Companies | Position | Start |
|---|---|---|
| The European Molecular Biology Laboratory | Corporate Officer/Principal | - |
Former positions of Joe D. Lewis
| Companies | Position | End |
|---|---|---|
| The University of Edinburgh | Corporate Officer/Principal | - |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Corporate Officer/Principal | - |
Elara Pharmaceuticals GmbH
 Elara Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Elara Pharmaceuticals GmbH focuses on the development of novel treatments for malignant diseases. It has developed three distinct and proprietary dual mechanism chemotypes that potently inhibit the HIF signaling pathway and induce apoptosis. The firm has identified compounds with excellent in vitro activity against a diverse set of tumor cell lines and superior pharmacokinetic and toxicity profiles in vivo. The company was founded by Frank Gannon, Joe D. Lewis and George Reid on July 27, 2006 and is headquartered in Heidelberg, Germany. | Chief Executive Officer | - |
Training of Joe D. Lewis
| University of Vienna | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Health Technology |
Elara Pharmaceuticals GmbH
Elara Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Elara Pharmaceuticals GmbH focuses on the development of novel treatments for malignant diseases. It has developed three distinct and proprietary dual mechanism chemotypes that potently inhibit the HIF signaling pathway and induce apoptosis. The firm has identified compounds with excellent in vitro activity against a diverse set of tumor cell lines and superior pharmacokinetic and toxicity profiles in vivo. The company was founded by Frank Gannon, Joe D. Lewis and George Reid on July 27, 2006 and is headquartered in Heidelberg, Germany. | Health Technology |
- Stock Market
- Insiders
- Joe D. Lewis